← Back to Search

Behavioral Intervention

Arm 1: CASI Intervention for Ovarian Cancer

N/A
Waitlist Available
Led By Rachel Pozzar, PhD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* At least 18 years old
* Able to speak, understand, and respond to questions written in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 12 (patient and caregiver participants) and 52 (clinician participants) weeks after enrollment
Awards & highlights

Summary

This research is being done to test a new communication tool for people with ovarian cancer, caregivers, and clinicians. The name of the intervention in this research study is: -Collaborative Agenda-Setting Intervention (CASI)

Eligible Conditions
  • Ovarian Cancer
  • Ovarian Tumors

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 12 (patient and caregiver participants) and 52 (clinician participants) weeks after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 12 (patient and caregiver participants) and 52 (clinician participants) weeks after enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Enrollment Rate
Secondary study objectives
Acceptability of Intervention
Change in FACT-G Score from Baseline to 12 Weeks (Arm 2)
Change in the Functional Assessment of Cancer Therapy - General (FACT-G) Score from Baseline to 12 Weeks (Arm 1)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1: CASI InterventionExperimental Treatment1 Intervention
Enrolled patients and caregivers will complete: * Audio recorded baseline visit * CASI via mobile device, laptop, or desktop computer 1 week prior to CASI visit 1 * Audio recorded CASI visit 1 * CASI via mobile device, laptop, or desktop computer 1 week prior to CASI visit 2 * Audio recorded CASI visit 2 * CASI via mobile device, laptop, or desktop computer 1 week prior to CASI visit 3 * Audio recorded CASI visit 3 * End of study visit For each enrolled patient, enrolled clinicians will complete: * Audio recorded baseline visit * Audio recorded CASI visit 1 * Audio recorded CASI visit 2 * Audio recorded CASI visit 3 Enrolled clinicians will also complete: * Baseline visit, one time * End of study visit, one time
Group II: Arm 2: ControlActive Control1 Intervention
Enrolled patients and caregivers will complete: * Audio recorded baseline visit * Audio recorded visit 1 will proceed according to usual, oncology care * Audio recorded visit 2 will proceed according to usual, oncology care * Audio recorded visit 3 will proceed according to usual, oncology care * End of study visit For each enrolled patient, enrolled clinicians will complete: * Audio recorded baseline visit * Audio recorded visit 1 will proceed according to usual, oncology care * Audio recorded visit 2 will proceed according to usual, oncology care * Audio recorded visit 3 will proceed according to usual, oncology care Enrolled clinicians will also complete: * Baseline visit, one time * End of study visit, one time

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,090 Previous Clinical Trials
343,610 Total Patients Enrolled
41 Trials studying Ovarian Cancer
4,652 Patients Enrolled for Ovarian Cancer
National Institute of Nursing Research (NINR)NIH
593 Previous Clinical Trials
10,380,615 Total Patients Enrolled
2 Trials studying Ovarian Cancer
660 Patients Enrolled for Ovarian Cancer
Rachel Pozzar, PhDPrincipal InvestigatorDana-Farber Cancer Institute
~75 spots leftby Sep 2025